India’s Obesity Crisis: A Growing Concern
Zerodha founder and chief executive officer Nithin Kamath has triggered a conversation on social media after sharing alarming numbers on rising obesity cases in India. Citing data from the country’s Economic Survey, Kamath stated that ’23–24% of Indians were already overweight or obese in 2019, nearly double the around 10% recorded two decades earlier’. This significant increase in obesity rates has severe implications for the country’s healthcare system and economy.
In a LinkedIn post shared just a day after World Obesity Day, Kamath wrote, “Yesterday was World Obesity Day. I hate to be the guy who complains, but the numbers are scary,” while highlighting alarming trends in obesity rates among adults and children in the country. The post also pointed to a sharp rise in childhood obesity, with ‘around 3.3 crore children obese in 2020, and the number projected to reach 8.3 crore by 2035’.
Causes of the Obesity Crisis
Kamath attributed much of this increase to the growing consumption of ultra-processed foods (UPFs), whose sales surged from $0.9 billion (₹7,500 crore) to $38 billion (₹3.16 lakh crore) over the years, during which obesity rates nearly doubled. UPF sales grew by more than 150% between 2009 and 2023, indicating that consumption is accelerating rather than slowing.
Furthermore, Kamath noted that ‘even children under 5 aren’t spared. Excess weight prevalence jumped from 2.1% to 3.4% in just 5 years (2015-2021)’. This trend is particularly concerning, as it suggests that the obesity crisis is affecting even the youngest members of society.
Lifestyle Changes to Combat Obesity
Sharing lifestyle suggestions, Kamath urged people to focus on healthier habits. “Try to eat homemade food and get quality ingredients. The more meals you eat outside, the more garbage that goes into your body,” he wrote. He also advised people to question the source and quality of food, walk for at least 30 minutes daily, sleep seven to eight hours, and reduce children’s exposure to packaged snacks and screen time.
Additionally, Kamath emphasized the importance of regular exercise and a balanced diet in maintaining a healthy weight. By making these simple changes, individuals can significantly reduce their risk of obesity and related health problems.
GLP-1 Drugs and the Future of Healthcare
Kamath also reiterated his stance on a possible shift in India’s healthcare landscape, noting that several pharmaceutical companies are preparing to launch GLP-1 drugs in the country once patents expire. These medicines are part of the global weight-loss drug trend associated with treatments like Ozempic.
Reflecting on the development, Kamath said, “On a different note, I just read that major Indian pharma companies are preparing to launch GLP-1 drugs in India after the patent expires this month… I’m wondering about what the first and second-order effects will be.” The introduction of these drugs could have significant implications for the healthcare industry and the economy as a whole.
Conclusion
In conclusion, India’s obesity crisis is a pressing concern that requires immediate attention. The alarming rise in obesity rates among adults and children has severe implications for the country’s healthcare system and economy. By making lifestyle changes and promoting healthier habits, individuals can reduce their risk of obesity and related health problems. The introduction of GLP-1 drugs could also play a significant role in combating the obesity crisis, and it will be interesting to see how this development unfolds in the coming months.
As Indian investors and traders, it is essential to stay informed about the latest developments in the healthcare industry and their potential impact on the economy. By staying ahead of the curve, individuals can make informed investment decisions and navigate the complex landscape of the Indian stock market.